HEALTH● LOWJul 29 · Jul 29, 2026, 5:47 PM
Allogene rises as FDA offers Fast Track, RMAT tags to cell therapy
Seeking Alpha Tech
Allogene's stock rose after the FDA granted Fast Track and RMAT designations to its cell therapy. This indicates expedited regulatory review for a potentially significant medical treatment.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH18m agoEbola: Lagos Intensifies Surveillance, Reassures Residents Of PreparednessChannels TVHEALTH45m agoLagos govt on alert, says no Ebola case in stateVanguard NigeriaHEALTH2h agoSummit Therapeutics reports survival benefit for cancer drug in trialSeeking Alpha TechHEALTH2h agoUganda orders 21-day Ebola quarantine for citizens returning from DR CongoAl Jazeera [en]